Here are 19 key notes on orthopedic and spine device companies over the past week.
ACell named Patrick McBrayer president and CEO.
Former Medtronic CEO Bill Hawkins took the helm at Bioventus's board.
Extremity Medical's KinematX Modular Hemi Wrist was successfully used in a surgical procedure.
Intellijoint Surgical won the 2015 North American Frost & Sullivan Award for Enabling Technology Leadership from Frost & Sullivan.
K2M fourth quarter revenue grew around 10 percent to 11 percent to around $54.4 million.
Kapstone Medical and Band-Lok received a U.S. patent for the Band-Lok Tether Clamp and Implantation System.
The FDA approved Medtronic's U.S. launch of the OsteoCool Ablation System.
Atlantic Health System's Overlook Medical Center in Summit, N.J., and Morristown (N.J.) Medical Center are now using the Medtronic's O-arm Intra-operative Imaging System.
For the second quarter of 2016, Medtech reported revenue of nearly $3.1 million, up from nearly $1.2 million in the second quarter of 2015.
MiMedx signed a definitive agreement to acquire Stability Biologics.
Nanotherapeutics granted an exclusive worldwide license to its proprietary bone void filler product to Amend Surgical.
Wall Street analysts covering NuVasive have set a consensus price target of $60.50 on the company's stock, shortly after the company announced its plan to acquire Ellipse Technologies.
NuVasive anticipates revenue will reach around $811 million in 2015, a 6 percent increase over 2014.
SeaSpine reported fourth quarter revenue is expected to reach $35 million, flat compared to the same period last year.
Smith & Nephew acquired BST-CarGel, a first-line cartilage repair product.
SpineGuard reported 43 percent annual revenue growth in 2015.
On Dec. 30, 2015, Spine Injury Solutions received notice from Professional Testing of successful completion of compliance testing for the Quad Video HALO System.
Allen Chang, founder of Vertera Spine, was named to Forbes' "30 Under 30" list in the manufacturing and industry sector for 2016.
In the fourth quarter of 2015, VEXIM's sales reached $4.58 million, a 44 percent increase from the same period the year prior.